Reset Map3 Results
上海市浦东新区芙蓉花路118弄11幢2层 2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai 浦东新区, 上海, 201315 ChinaShanghai Sailybio medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio medical Co.,Ltd. to continue to provide excellent services to everyone.
上海市浦东新区芙蓉花路118弄11幢2层 浦东新区, 上海, 201315 ChinaShanghai Sailybio medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio medical Co.,Ltd. to continue to provide excellent services to everyone.
上2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai 2nd Floor, Building 11, Lane 118, Furonghua Road, Pudong New Area, Shanghai PUDONGXINGQU, Shanghi, 201315 ChinaShanghai Sailybio medical Co.,Ltd., formerly known as Shanghai Sailybio Biotechnology Co., Ltd., and Shanghai Xuanfeng Biotechnology Co., Ltd., is committed to promoting the development of the global pharmaceutical industry after strategic upgrading and adjustment in 2024. Since its establishment in 2015, we have always adhered to the mission of "continuously creating higher value for customers and employees", serving the field of innovative drug research and development, and striving to become a global competitive pharmaceutical enterprise service provider. The company has built more than 1,000 square meters of R&D laboratories, and has a biomedical R&D and clinical project management team with rich industry experience, which can provide industry customers with professional and regulatory requirements for primary cell preparation and separation, preclinical druggability evaluation, clinical project services, and reagent consumables services. With the continuous expansion of business and continuous innovation of technology, we have carried out strategic upgrading and adjustment in 2024 and officially changed our name to Shanghai Sailybio medical Co.,Ltd., This strategic realignment not only marks the further expansion of our business areas, but also our commitment to provide customers with higher quality services. The company's history is as follows: In May 2015, Shanghai Sailybio Biotechnology Co., Ltd. was established. In May 2016, Shanghai Xuanfeng Biotechnology Co., Ltd. was established. In 2017, it provided human peripheral blood mononuclear cell isolation services in the industry. In 2019, it established a clinical service team to provide services such as clinical trial application, approval and management, and joined the Chinese Society of Cell Biology. In 2020, it obtained the record certificate of Shanghai Pathogenic Microbiology Laboratory and won the Shanghai High-tech Enterprise. In 2021, a technical service platform will be established to provide in vitro efficacy function verification services. In 2022, Shanghai Sailybio Biotechnology Co., Ltd. passed GB/T 19001-2016/ISO 9001:2015 quality system certification. 2024 Obtained laboratory animal license. In 2024, the company will be strategically upgraded and adjusted, and the company's business will be fully transferred to Shanghai Sailybio medical Co.,Ltd. to continue to provide excellent services to everyone.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.